OTCMKTS:PBSV

Pharma-Bio Serv - PBSV Stock Forecast, Price & News

$1.00

+0.06 (+6.38%)

(As of 03/30/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.94
▼
$1.00
50-Day Range: $0.80
▼
$1.17
52-Week Range: $0.58
▼
$1.20

Volume: 12,262 shs
Average Volume: 11,304 shs
Market Capitalization: $22.97 million

P/E Ratio: 20.00
Dividend Yield: N/A
Price Target: N/A

About Pharma-Bio Serv (OTCMKTS:PBSV) Stock

Pharma-Bio Serv, Inc. engages in the provision of technical compliance consulting service and microbiological and chemical laboratory testing services to the pharmaceutical, chemical, medical device and biotechnology industries. It operates through the following business segments: Puerto Rico Technical Compliance Consulting; United States Technical Compliance Consulting; and Europe Technical Compliance Consulting. The company was founded in February 1993 and is headquartered in Dorado, Puerto Rico.

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

March 24, 2023 | americanbankingnews.com

Pharma-Bio Serv, Inc. (PBSV) to Issue Dividend of $0.08 on April 14th

March 22, 2023 | americanbankingnews.com

Equities Analysts Issue Forecasts for Pharma-Bio Serv, Inc.'s Q3 2023 Earnings (OTCMKTS:PBSV)

March 30, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

March 20, 2023 | finance.yahoo.com

PBSV: A Steady Performer with Upside Potential

March 17, 2023 | finance.yahoo.com

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023

March 7, 2023 | markets.businessinsider.com

4 Analysts Have This to Say About BridgeBio Pharma

March 3, 2023 | markets.businessinsider.com

SVB Securities Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)

February 21, 2023 | marketwatch.com

Bio Pharma Buffer Market 2023: Emerging Trends and Best Practices in Futurism till 2028

March 30, 2023 | WealthPop (Ad)

Adam Mesh: “This Strategy Saved My Trading Career”

Adam Mesh was $50,000 in the hole - and ready to quit trading for good… Until he discovered the secret to unlocking double-digit income. This strategy has averaged 64% average gains in the last three years. Adam is hosting a free session to show ordinary folks how to execute this incredible strategy. Click here to let Adam show you how it’s done.

February 16, 2023 | marketwatch.com

Bio Pharma Logistics Market Growth, Business Overview and Forecast to 2028

February 14, 2023 | marketwatch.com

Bio Pharma Buffer Market Size, Share and Forecast 2028 with Top Countries Data

February 7, 2023 | finanznachrichten.de

Pharma-Bio Serv Inc.: Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services

February 7, 2023 | finance.yahoo.com

Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services

February 3, 2023 | finance.yahoo.com

PBSV: Ready for Post-Pandemic Growth

February 2, 2023 | marketwatch.com

Bio-Pharma Market Profiled Key Players to Show Impressive Revenue Growth by 2029

February 1, 2023 | msn.com

AGC Biologics in Bothell to produce new diabetes treatment

February 1, 2023 | msn.com

AGC Biologics in Bothell to produce new diabetes treatment

January 30, 2023 | finance.yahoo.com

Pharma-Bio Serv Announces Full Year Results

January 26, 2023 | benzinga.com

Global Bio analytical Testing Services Market to Surpass US$ 7,749.5 Million by 2030, Says Coherent Market Insights (CMI)

January 19, 2023 | msn.com

Sun Pharma to buy US biotech firm for $576mn

January 18, 2023 | seekingalpha.com

BridgeBio Pharma: The Hub-And-Spoke Model Is Complicated And Confusing

January 9, 2023 | benzinga.com

BANTAM PHARMACEUTICAL TO PRESENT AT BIOTECH SHOWCASE™ 2023

January 7, 2023 | seekingalpha.com

ImmunityBio: Upcoming PDUFA, Solid Data, Confusing Finances

January 4, 2023 | technews.tmcnet.com

Massive Bio Announces Plans to Expand AI Use in Oncology, from Clinical Trial Matching to Drug Matching and Beyond

November 18, 2022 | marketwatch.com

The Biopharma Report is one of the fastest-growing online newsletters focused on the pharmaceutical and biotechnology industry.

November 2, 2022 | marketwatch.com

Bioactive Wound Care Market is Estimated to Accelerate Industry Development in Pharma & Healthcare Sector with Top Key Players till 2028

October 22, 2022 | marketwatch.com

Bio Pharma Buffer Market Is Expected To Progress At A Fast Rate During Forecast 2022 To 2028

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Company Calendar

Last Earnings: 1/30/2023
Ex-Dividend for 4/14 Dividend: 3/28/2023
Today: 3/30/2023
Dividend Payable: 4/14/2023
Fiscal Year End: 10/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Management consulting services
Sub-Industry: N/A
Sector: Business Services
Current Symbol: OTCMKTS:PBSV
CUSIP: N/A
CIK: 1304161
Web: www.pharmabioserv.com
Phone: (787) 278-2709
Fax: 787-796-5168
Employees: 190
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.05
Trailing P/E Ratio: 20.00
Forward P/E Ratio: 11.11
P/E Growth: N/A
Net Income: $1.01 million
Net Margins: 6.05%
Pretax Margin: 7.56%
Return on Equity: 6.87%
Return on Assets: 5.49%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.32
Quick Ratio: 10.32

Sales & Book Value

Annual Sales: $19.40 million
Price / Sales: 1.18
Cash Flow: $0.04 per share
Price / Cash Flow: 25.50
Book Value: $0.74 per share
Price / Book: 1.35

Miscellaneous

Outstanding Shares: 22,970,000
Free Float: 20,096,000
Market Cap: $22.97 million
Optionable: Not Optionable
Beta: 0.32

Key Executives

Victor Sanchez
President & Chief Executive Officer

Sandra Molina
Director-Puerto Rico Operations

Pedro J. Lasanta
CFO, Secretary & Vice President-Administration

Miriam Marrero
Manager-Human Resources

Key Competitors

View All Competitors

PBSV Stock - Frequently Asked Questions

How have PBSV shares performed in 2023?: Pharma-Bio Serv's stock was trading at $0.79 at the beginning of 2023. Since then, PBSV shares have increased by 26.6% and is now trading at $1.00.
View the best growth stocks for 2023 here.
How were Pharma-Bio Serv's earnings last quarter?: Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) released its earnings results on Monday, January, 30th. The company reported $0.01 earnings per share for the quarter. The business had revenue of $4.64 million for the quarter. Pharma-Bio Serv had a trailing twelve-month return on equity of 6.87% and a net margin of 6.05%.
How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?: Pharma-Bio Serv declared a dividend on Wednesday, March 22nd. Shareholders of record on Wednesday, March 29th will be given a dividend of $0.075 per share on Friday, April 14th. This represents a dividend yield of 7.75%. The ex-dividend date of this dividend is Tuesday, March 28th.
Read our dividend analysis for PBSV.
What other stocks do shareholders of Pharma-Bio Serv own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?: Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."
How do I buy shares of Pharma-Bio Serv?: Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Pharma-Bio Serv's stock price today?: One share of PBSV stock can currently be purchased for approximately $1.00.
How much money does Pharma-Bio Serv make?: Pharma-Bio Serv (OTCMKTS:PBSV) has a market capitalization of $22.97 million and generates $19.40 million in revenue each year. The company earns $1.01 million in net income (profit) each year or $0.05 on an earnings per share basis.
How many employees does Pharma-Bio Serv have?: The company employs 190 workers across the globe.
How can I contact Pharma-Bio Serv?: Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The official website for the company is www.pharmabioserv.com. The company can be reached via phone at (787) 278-2709, via email at scottg@corprominence.com, or via fax at 787-796-5168.

This page (OTCMKTS:PBSV) was last updated on 3/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial